Exon News and Research

RSS
ALK fusion variants could influence NSCLC crizotinib response

ALK fusion variants could influence NSCLC crizotinib response

Rice University researchers synthesize new anti-cancer agent

Rice University researchers synthesize new anti-cancer agent

Researchers clarify cause of heart arrhythmia in myotonic dystrophy

Researchers clarify cause of heart arrhythmia in myotonic dystrophy

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

FDA approves blood-based cobas EGFR Mutation Test v2 for NSCLC patients

Studies confirm benefit of plasma genotyping to predict treatment outcomes for NSCLC patients

Studies confirm benefit of plasma genotyping to predict treatment outcomes for NSCLC patients

UT Southwestern scientists discover mutation that causes X-linked reticulate pigmentary disorder

UT Southwestern scientists discover mutation that causes X-linked reticulate pigmentary disorder

OGT launches new CytoSure Constitutional v3 +LOH array for genetic analysis of developmental disorders

OGT launches new CytoSure Constitutional v3 +LOH array for genetic analysis of developmental disorders

Rare ADCY9 mutations linked to non-syndromic oral clefts in Puerto Ricans

Rare ADCY9 mutations linked to non-syndromic oral clefts in Puerto Ricans

Tick genome study sheds light on occurrences of Lyme disease

Tick genome study sheds light on occurrences of Lyme disease

Penn investigators devise new method to map 'transcriptome'

Penn investigators devise new method to map 'transcriptome'

Duchenne muscular dystrophy: direct effect on muscle stem cells? An interview with Dr Rudnicki

Duchenne muscular dystrophy: direct effect on muscle stem cells? An interview with Dr Rudnicki

Alternative splicing: a new approach to drug development? An interview with Lucy Donaldson

Alternative splicing: a new approach to drug development? An interview with Lucy Donaldson

Adjuvant Chemotherapy Colon Cancer Trials Should ‘Stratify By MSI, KRAS, BRAF’

Adjuvant Chemotherapy Colon Cancer Trials Should ‘Stratify By MSI, KRAS, BRAF’

Researchers successfully use CRISPR to treat adult mouse model of Duchenne muscular dystrophy

Researchers successfully use CRISPR to treat adult mouse model of Duchenne muscular dystrophy

Mirati announces initiation of glesatinib Phase 2 clinical trial in NSCLC patients

Mirati announces initiation of glesatinib Phase 2 clinical trial in NSCLC patients

Researchers find new way to prevent or reduce pathologies caused by malformed proteins

Researchers find new way to prevent or reduce pathologies caused by malformed proteins

New study finds a reason for ethnic disparity in CF diagnoses

New study finds a reason for ethnic disparity in CF diagnoses

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

IASLC commends FDA's decision to grant accelerated approval for new lung cancer therapy

Baylor Miraca Genetics Laboratories licenses SNP probe technology from OGT

Baylor Miraca Genetics Laboratories licenses SNP probe technology from OGT

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.